RavenQuest "21 Reasons Report" Update When will the investment world wake up and realize that RavenQuest is the YouTube of cannabis - patiently waiting for a Google to take them over?
As RavenQuest awaits Health Canada's amendment to grow OG 2.0 in all 8 rooms, several insights were made clear last week by one of Canada's top cannabis thought leaders - George Robinson.
RavenQuest Client Achieves Landmark Success: Bonify Sales License Fully Reinstated by Health Canada
CBC, CTV, BNNBloomberg (print and TV Interview with Andrew Bell) Financial Post, and a few other articles followed up at Google News.
James O'Hara tweeted this:
"If there’s any unsung hero in this tale, it’s @RQBGlobal, George Robinson and staff. George’s willingness to step in, assist, and raise Bonify standards was not without risk - even by association. A tip of the hat to RavenQuest is more than well-deserved." https://mobile.twitter.com/James_G_OHara/status/1187333285048922113
George Robinson talks to James West about the benefits of his 3 1/2 years working closely with McGill:
"What it really means is this: you can go anywhere from studying cannabis in law, Finance, which are outliers when you think of cannabis, but now you can be in toxicology. You can be a neurology. You can be in Paediatrics. You can be in Imaging. You can be in drug Discovery. You can be in plant Sciences. All those researchers work to get together on the same campus with the same overarching guidelines that this will be a positive for the school where many other places have researchers that are working at different universities. But researcher to researcher is very different than a whole campus and a whole school backing it from a funding perspective. Backing from an experience for the researchers. So, this is where I see the benefit of it. And right now it’s the largest institution or even University that’s backing up with six faculties and 92 researchers." https://midasletter.com/2019/10/ravenquest-biomed-inc-cnsxrqb-client-bonify-achieves-landmark-health-canada-licence-reinstation/
As the top 20 cannabis stocks continue to correct, by over-promising ($TRST laid off 320 and $HEXO 200) and under-delivering, the hard question is: when will the trickle down theory kick in?
Approximately 20 years ago, some of the bloated multi-billion dollar Internet stocks were evaluated at 200 times trailing revenue (let alone earnings!). A few of the astute companies with lofty prices were able to use their shares as currency, and take over smaller stocks with innovative technology, and potentially lucrative future revenue streams. 8 years later, the real big deals kicked in.
In 2006, Google bought YouTube for $1.65 billion (67 employees). Today, YouTube is estimated to be worth up to $160 billion.
In the cannabis space, the dollar amounts and Market Caps are indeed significantly smaller. However, the percentage gains will once again become attractive upon the next round of consolidations.